Las Vegas, NV (PRWEB) July 13, 2011
EQ Biosciences, Inc. today announced its public pre-launch of the world’s leading disease preventative nutritional supplement, Prevennia. Scientifically proven to block DNA damage, Prevennia will change the way the world thinks about health, as it is proven effective in preventing the cell mutations that could lead to the formation of life altering disease.
Prevennia was created by doctors searching for the origin of the cancer cell. It is the body’s first line of defense against preventing a number of life altering diseases.
Prevennia has been researched for over 40 years and supported by $38 million of grants. Research scientists, Dr. Eleanor Rogan and Dr. Ercole Cavalieri, of the Eppley Institute for Cancer Research and Allied Diseases at the University of Nebraska Medical Center in Omaha, discovered that elevated levels of estrogen-DNA-adducts, in both men and women, are present in cancer victims as well as those who have had cancer. The conclusion from their research was that imbalances of estrogen-DNA-adducts can cause damage to DNA. Damaged DNA cells have the ability to turn into cancerous or diseased cells.
The research scientists, after scientifically proving that estrogen was the origin of the cancer cell, created a product that could block the high levels of estrogen-DNA-adducts from reacting with the DNA and causing damage. This effectively stopped the first step in the formation of mutant cells that could lead to cancer.
Prevennia is the first dietary supplement of its kind. It is scientifically proven to keep the body in balance, block DNA damage and enhance the immune system by balancing estrogen metabolism.
“When I was first introduced to doctors Rogan and Cavalieri, I was impressed with the body of research and the scientific discoveries these two research scientists had made over the past forty years, but more importantly, I was enthralled with their passion, belief and un-relinquishing desire to get Prevennia into the hands of every person across America and eventually the world. They truly believe in their life’s work and need to be recognized for their contributions to science and society,” states John Raffanti, President and CEO of EQ Biosciences, Inc.
Making it his life’s mission to spread the word about this life-changing supplement that will give people the balance they need to live healthier, more active lives, Raffanti is surging ahead despite the competitive market of nutritional supplements, knowing Prevennia is unlike anything available today.
Currently in the beginning stages of conducting clinical trials to support the scientific evidence, Prevennia is being made available to the public online at Prevennia.com.
“Think of Prevennia as an insurance policy against life altering disease. For less than $2 a day, people will be able to sleep at night knowing they are doing what is necessary to protect their bodies from infectious diseases such as cancer. We aren’t saying you will not get cancer by taking Prevennia, but you will be helping to block the estrogen-DNA-adducts that lead to cell mutation, which could ultimately lead to cancerous cells,” enforces Raffanti.
Over the past three decades, the National Cancer Institute and Department of Defense granted $38 million to the award-winning researchers who created Prevennia. These researchers have been conducting scientific studies, proving in laboratory testing, that the unique combination of the all-natural antioxidants in Prevennia blocks the triggering mechanism that causes DNA degradation by keeping estrogen metabolism in balance. This means, in theory, Prevennia has the ability to block the first step that leads down the pathway to many cancers, including breast and prostate cancer.
Read the full story at http://www.prweb.com/releases/prevennia/nutritionalsupplement/prweb8638421.htm